Results 321 to 330 of about 3,688,101 (379)

Prodrug Strategy Extends the Use of Anti-HIV Sulfanylbenzamides for Application In Vivo. [PDF]

open access: yesACS Pharmacol Transl Sci
Robello M   +5 more
europepmc   +1 more source

Combination antiretroviral therapy and the risk of myocardial infarction [PDF]

open access: yes, 2003
Abbadesse, V   +535 more
core  

In vitro anti-HIV, cytotoxicity and nutritional analysis of Trianthema portulacastrum L. (Aizoaceae). [PDF]

open access: yesBMC Complement Med Ther
Jimoh MA   +6 more
europepmc   +1 more source

The anti-HIV drug abacavir stimulates β-catenin activity in osteoblast lineage cells. [PDF]

open access: yesJBMR Plus
Olali AZ   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

1,2,3‐Triazole hybrids with anti‐HIV‐1 activity

Archiv der Pharmazie, 2020
The human immunodeficiency virus type 1 (HIV‐1) is the major etiological agent responsible for the acquired immunodeficiency syndrome (AIDS), which is a serious infectious disease and remains one of the most prevalent problems at present.
Lian-Shun Feng   +3 more
semanticscholar   +1 more source

Anti-HIV ribozymes

Molecular Biotechnology, 1997
HIV is an RNA virus that replicates intracellularly through various RNA intermediates. Several of these can be targeted by ribozymes (catalytic RNA molecules), and a number of investigators, including this group, have demonstrated the ability of ribozymes to suppress HIV replication in this way.
L Q, Sun   +3 more
openaire   +2 more sources

Anti-HIV Cyclotides

Current Protein & Peptide Science, 2004
The cyclotides are a recently discovered, structurally unique family of bioactive plant peptides. Their discovery spawned a series of structural analyses, synthetic efforts, and studies to define the biosynthesis and biological properties of these novel peptide metabolites.
Kirk R, Gustafson   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy